These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Issues in stinging insect allergy immunotherapy: a review. Finegold I Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):343-7. PubMed ID: 18596592 [TBL] [Abstract][Full Text] [Related]
26. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy. Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233 [TBL] [Abstract][Full Text] [Related]
30. American Academy of Asthma, Allergy & Immunology membership experience with venom immunotherapy in chronic medical conditions and pregnancy, and in young children. Calabria CW; Hauswirth DW; Rank M; Sher L; Larenas-Linnemann D Allergy Asthma Proc; 2017 Mar; 38(2):121-129. PubMed ID: 28234049 [TBL] [Abstract][Full Text] [Related]
31. Omalizumab in chronic urticaria. Metz M; Maurer M Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):406-11. PubMed ID: 22766620 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. Brockow K; Kiehn M; Riethmüller C; Vieluf D; Berger J; Ring J J Allergy Clin Immunol; 1997 Oct; 100(4):458-63. PubMed ID: 9338537 [TBL] [Abstract][Full Text] [Related]
33. Venom immunotherapy in indolent systemic mastocytosis with high serum tryptase level. Selcuk A; Baysan A Hum Vaccin Immunother; 2021 Jun; 17(6):1599-1603. PubMed ID: 33651660 [TBL] [Abstract][Full Text] [Related]
35. Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab. Bell MC; Jackson DJ Ann Allergy Asthma Immunol; 2012 May; 108(5):383-4. PubMed ID: 22541416 [No Abstract] [Full Text] [Related]
36. Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis. Carter MC; Robyn JA; Bressler PB; Walker JC; Shapiro GG; Metcalfe DD J Allergy Clin Immunol; 2007 Jun; 119(6):1550-1. PubMed ID: 17481708 [No Abstract] [Full Text] [Related]
37. Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis. Kibsgaard L; Skjold T; Deleuran M; Vestergaard C Acta Derm Venereol; 2014 May; 94(3):363-4. PubMed ID: 24162824 [No Abstract] [Full Text] [Related]
38. An Increase in Tryptase on the First Day of Hymenoptera Venom Immunotherapy Might Be a Predictor of Future Systemic Reactions During Treatment. Vega-Castro A; Alonso-Llamazares A; Cárdenas R; Beitia JM; Mateo B; Alvarez-Twose I; Blanco C J Investig Allergol Clin Immunol; 2018 Oct; 28(5):305-311. PubMed ID: 29589586 [TBL] [Abstract][Full Text] [Related]